ArticleDrug design, development and therapy2025

Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway.

Yingxu Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.